25C-NBOMe: Difference between revisions

Line 15: Line 15:
*Visual/Auditory hallucinations
*Visual/Auditory hallucinations
*Stimulation +/- tremors, bruxism
*Stimulation +/- tremors, bruxism
*[[Serotonin Syndrome]] ([[AMS]], [[Hyperthermia]], rigidity, autonomic instability)
*[[Serotonin Syndrome]] ([[AMS]], [[Hyperthermia]], rigidity, autonomic instability)<ref>Boyer EW, Shannon M. The serotonin syndrome. NEJM. 2005;352:1112-20</ref>
*Confusion
*Confusion
*Agitation
*Agitation

Revision as of 21:53, 18 December 2014

25C-NBOMe

Background

  • 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
  • Other names: NBOMe-2C-C, Boom, C-Boom, Cimbi-82, Pandora, N-bomb, Holland film, Dime
  • Potent partial agonist of 5-HT2A receptor
  • Member of new class of toxic phenethylamine derivatives (NBOMe) with similar effects to LSD
  • Commonly ingested orally or sublingually; can also be ingested nasally, parenterally, vaginally, rectally
  • Dose of 50-200 micrograms causes hallucinogenic effects
  • Onset 0-15 mins, peak 30-90 mins, total duration 4-10 hours

Clinical Features

Workup

Hallucination workup

Treatment

Disposition

  • Admit pt's with complications of ingestion

See Also

Sources

Bersani FS, Corazza O, Albano G, et al. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int. 2014;2014:734749.

  1. Boyer EW, Shannon M. The serotonin syndrome. NEJM. 2005;352:1112-20